Stoke Therapeutics
STOK
26.81
-0.12
-0.45%
Stoke Therapeutics
US · STOK
#2942 by market cap
Listed 2019
26.81
-0.12
-0.45%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B-
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 6 analysts
Buy
Avg price target 48.33 +80.3%
Price target rangecurrent 26.81
Low39.00
Avg48.33
High60.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-02 | CCORF | -- | Buy | 58.00 |
| 2026-11-02 | H.C. Wainwright | -- | Buy | 50.00 |
| 2026-11-01 | BTIG | -- | Buy | 39.00 |
| 2026-10-30 | Goldman Sachs | -- | Buy | 43.00 |
| 2026-10-13 | TD Cowen | -- | Buy | 60.00 |
| 2026-10-12 | BTIG | -- | Buy | 39.00 |
| 2026-10-05 | Goldman Sachs | -- | Buy | 44.00 |
| 2026-08-21 | J.P. Morgan | -- | Buy | 40.00 |
| 2026-08-12 | CCORF | -- | Buy | 58.00 |
| 2026-08-04 | TD Cowen | -- | Buy | 60.00 |
| 2026-08-04 | CCORF | -- | Buy | 58.00 |
| 2026-08-04 | Needham | -- | Buy | 40.00 |
| 2026-08-04 | H.C. Wainwright | -- | Buy | 50.00 |
| 2026-08-03 | Chardan Capital | -- | Buy | 35.00 |
| 2026-08-03 | Wolfe Research | -- | Buy | 40.00 |
| 2026-08-03 | BTIG | -- | Buy | 39.00 |
| 2026-08-03 | Goldman Sachs | -- | Buy | 44.00 |
| 2026-07-13 | Goldman Sachs | -- | Buy | 44.00 |
| 2026-07-09 | Needham | -- | Buy | 40.00 |
| 2026-06-02 | Leerink Partners | -- | Buy | -- |
| 2026-05-11 | BTIG | -- | Buy | 39.00 |
| 2026-05-08 | CCORF | -- | Buy | 60.00 |
| 2026-05-08 | Wedbush | -- | Buy | 38.00 |
| 2026-05-08 | Needham | -- | Buy | 40.00 |
| 2026-05-08 | H.C. Wainwright | -- | Buy | 50.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-29 | After close | ±16.84% | -0.23% (in line) |
| 2026/Q2 | 2026-08-03 | After close | ±10.11% | +7.14% (in line) |
| 2026/Q1 | 2026-05-07 | After close | ±17.54% | +0.31% (in line) |
| 2025/Q3 | 2025-11-04 | After close | ±20.89% | -9.94% (in line) |
| 2025/Q2 | 2025-08-12 | After close | ±20.92% | +24.98% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Stoke Therapeutics discussion 0 comments